{"id":"W4311456903","doi":"10.1016/j.jacadv.2022.100148","title":"Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial","year":2022,"lang":"en","type":"article","venue":"JACC Advances","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Janssen Biotech; Pfizer UK; Pfizer","keywords":"Medicine; Placebo; Confidence interval; Odds ratio; Internal medicine; Clinical trial; Randomized controlled trial; Cardiomyopathy; Transthyretin; Physical therapy; Heart failure; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188353,0.0002606824,0.0004256544,0.0001126293,0.0000919091,0.00002411954,0.0004898644,0.0000961538,0.00001842674],"category_scores_gemma":[0.0002016007,0.0001883189,0.0001804036,0.0003934989,0.0001193934,0.00001536735,0.0001140221,0.0003321392,0.000002304559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008407438,"about_ca_system_score_gemma":0.0001116885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002059386,"about_ca_topic_score_gemma":0.001772852,"domain_scores_codex":[0.9972173,0.0007374382,0.0006194395,0.0006350094,0.0003899147,0.0004009005],"domain_scores_gemma":[0.9991194,0.0001833833,0.0001673736,0.0004607422,0.00002045315,0.00004863293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01910866,0.003018329,0.8939798,0.00002531578,0.0001273345,0.0002017147,0.0009382244,0.002249829,0.002286625,0.00003549496,0.0003559086,0.0776727],"study_design_scores_gemma":[0.1655619,0.01067286,0.67953,0.00008214064,0.0001546553,0.00003058559,0.009166567,0.00004628173,0.00984676,0.0003455914,0.1232139,0.001348786],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936201,0.003836243,0.00005307045,0.0005801493,0.0002621055,0.001257721,0.0000487665,0.00001107091,0.0003307692],"genre_scores_gemma":[0.996192,0.001548888,0.0001752837,0.0005511678,0.0001409963,0.001230759,0.00009104968,0.00002827242,0.00004157893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2144499,"threshold_uncertainty_score":0.7679422,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02641622557964836,"score_gpt":0.3325781476394969,"score_spread":0.3061619220598485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}